Novartis Pharmaceuticals Corporation v. Apotex Inc. - 1:26-cv-01281

Novartis Pharmaceuticals Corporation v. Apotex Inc. (Case No. 1:26-cv-01281), filed on Oct 5, 2026 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:26-cv-01281
Filing Date
Oct 5, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Novartis Pharmaceuticals Corporation -
Apotex Inc. -

Patents Involved

This case involves 6 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 5, 2026Summons Issued as to Apotex Corp. on 10/5/2026; Apotex Inc. on 10/5/2026. (Attachments: # 1 Summons Issued)(mpb) (Entered: 10/05/2026)PACER Document
Oct 5, 2026Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation - filed by Novartis Pharmaceuticals Corporation. (mpb) (Entered: 10/05/2026)PACER Document
Oct 5, 2026Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,580,304; 9,155,706; 9,271,941; 9,399,021 ; 8,703,781; 10,869,869. (Attachments: # 1 Patent/Trademark Report)(mpb) (Entered: 10/05/2026)PACER Document
Oct 5, 2026Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/1/2026. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: no earlier than 3/1/2029. (mpb) (Entered: 10/05/2026)PACER Document
Oct 5, 2026Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 10/05/2026)PACER Document
Oct 5, 2026COMPLAINT against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-5082468) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-F, # 2 Civil Cover Sheet)(mpb) (Entered: 10/05/2026)PACER Document
Oct 5, 2026COMPLAINT against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-5082468) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-F, # 2 Civil Cover Sheet)(mpb) (Entered: 10/05/2026)Attachment
Oct 5, 2026COMPLAINT against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-5082468) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-F, # 2 Civil Cover Sheet)(mpb) (Entered: 10/05/2026)Attachment